SLP

Simulations Plus, Inc.

Technology · $373M market cap

Verdict

Share price

$18.50

close of Oct 3, 2026

Fair value

$11.80

Sticker Price

Payback Price

$4.72

buy price

Overpriced

SLP is Overpriced: at $18.50 it trades 57% above its fair value of $11.80. Its buy price (Payback Price) is $4.72, 74% below today's price. Business quality is strong: 4 of 5 key numbers clear the 10% bar.

How we valued it

Free Cash Flow. Sales grew 14% a year over the last 3 years, below the 15% we look for in a fast grower, so we value it on its free cash flow instead of an earnings forecast.

Business quality

4 of 5 clear the 10% bar. What are the Big Five?

Earnings per share growth15.4% a year✓
Equity per share growth16.8% a year✓
Sales growth14.8% a year✓
Free cash flow growth15.3% a year✓
Return on invested capital-15.3%✗

Follow SLP

Get notified when it reaches its buy price of $4.72. Free.

Create a free account

Superinvestors

1 of the investors we track holds SLP. In Q2 2026, 1 added. Who we track

Moves in Q2 2026

Added: First Eagle Investment Management

Insider activity

Since Jun 15, 2026: no open-market purchases, 5 sales worth $265K and 2 other filings (stock awards, tax withholding and similar). Why purchases matter

Sales

Other filings

About Simulations Plus, Inc.

Simulations Plus, Inc. (SLP) is a worldwide developer of sophisticated software and services aimed at enhancing drug discovery and development processes. The company employs artificial intelligence and machine learning technologies to create tools for modeling, simulation, and predicting molecular characteristics. Its operations are divided into four main business units: Simulations Plus, Cognigen, DILIsym, and…

Software - Application

Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works